MetaADEDB 2.0 @ LMMD
Vilazodone Hydrochloride
(RPZBRGFNBNQSOP-UHFFFAOYSA-N)
Structure
SMILES
N#Cc1ccc2c(c1)c(CCCCN1CCN(CC1)c1ccc3c(c1)cc(o3)C(=O)N)c[nH]2.Cl
Molecular Formula:
C26H28ClN5O2
Molecular Weight:
477.986
Log P:
5.5348
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
3
TPSA:
102.29
CAS Number(s):
163521-08-2
Synonym(s)
1.
Vilazodone Hydrochloride
2.
2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)
3.
5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide
4.
EMB-68843
5.
EMD 68843
6.
Viibryd
7.
Vilazodone
8.
Vilazodone HCl
9.
68843, EMD
10.
EMB 68843
11.
EMB68843
12.
HCl, Vilazodone
13.
Hydrochloride, Vilazodone
External Link(s)
MeSHD000069503
PubChem Compound6918313
ChEBI70705
CHEMBLCHEMBL1615374
KEGGdr:D09699
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 187US FAERS
2HeadacheFAERS: 128US FAERS
3AnxietyFAERS: 121US FAERS
4DizzinessFAERS: 111US FAERS
5Drug ineffectiveFAERS: 93
Canada Vigilance: 1
Canada Vigilance
US FAERS
6Feeling abnormalFAERS: 85US FAERS
7AgitationFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
8TremorFAERS: 60US FAERS
9VomitingFAERS: 49US FAERS
10FatigueFAERS: 46US FAERS
11PalpitationsFAERS: 43US FAERS
12PruritusFAERS: 42US FAERS
13SomnolenceFAERS: 40US FAERS
14CryingFAERS: 39US FAERS
15Serotonin SyndromeFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Drug dose omissionFAERS: 34US FAERS
17AngerFAERS: 33US FAERS
18Wrong technique in product usage processFAERS: 32US FAERS
19AlopeciaFAERS: 30US FAERS
20Abdominal discomfortFAERS: 29US FAERS
21Completed SuicideFAERS: 28US FAERS
22Intentional product misuseFAERS: 28US FAERS
23MalaiseFAERS: 27US FAERS
24Suicide attemptFAERS: 27US FAERS
25Sleep ParalysisFAERS: 26US FAERS
26Feeling jitteryFAERS: 23US FAERS
27TinnitusFAERS: 21US FAERS
28Unevaluable eventFAERS: 21US FAERS
29ArthralgiaFAERS: 20US FAERS
30AstheniaFAERS: 20US FAERS
31Sexual DysfunctionFAERS: 19US FAERS
32PainFAERS: 18US FAERS
33ParanoiaFAERS: 18US FAERS
34AmnesiaFAERS: 17US FAERS
35LethargyFAERS: 16US FAERS
36MyalgiaFAERS: 16US FAERS
37NervousnessFAERS: 16US FAERS
38RestlessnessFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Restless Legs SyndromeFAERS: 14US FAERS
40Memory impairmentFAERS: 13US FAERS
41Abdominal PainFAERS: 12US FAERS
42Musculoskeletal stiffnessFAERS: 12US FAERS
43Night sweatsFAERS: 12US FAERS
44Product dose omissionFAERS: 12US FAERS
45Blood glucose increasedFAERS: 11US FAERS
46Incorrect dose administeredFAERS: 11US FAERS
47SyncopeFAERS: 11US FAERS
48ConstipationFAERS: 10US FAERS
49DisorientationFAERS: 10US FAERS
50Drug withdrawal syndromeFAERS: 10US FAERS
51FlatulenceFAERS: 10US FAERS
52Adverse eventFAERS: 9US FAERS
53DyspepsiaFAERS: 9US FAERS
54Expired product administeredFAERS: 9US FAERS
55Product prescribing errorFAERS: 9US FAERS
56ScreamingFAERS: 9US FAERS
57Therapeutic response unexpectedFAERS: 9US FAERS
58Accidental overdoseFAERS: 8US FAERS
59Chest discomfortFAERS: 8US FAERS
60Depressed moodFAERS: 8US FAERS
61Emotional disorderFAERS: 8US FAERS
62Erectile dysfunctionFAERS: 8US FAERS
63HypersensitivityFAERS: 8US FAERS
64Medication ErrorFAERS: 8US FAERS
65Mood swingsFAERS: 8US FAERS
66TachyphreniaFAERS: 8US FAERS
67Weight decreasedFAERS: 8US FAERS
68Accidental exposure to productFAERS: 7US FAERS
69BruxismFAERS: 7US FAERS
70Joint swellingFAERS: 7US FAERS
71Muscle tightnessFAERS: 7US FAERS
72StressFAERS: 7US FAERS
73TachycardiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
74UrticariaFAERS: 7US FAERS
75VertigoFAERS: 7US FAERS
76Chest PainFAERS: 6US FAERS
77DysgeusiaFAERS: 6US FAERS
78HostilityFAERS: 6US FAERS
79HypomaniaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Middle insomniaFAERS: 6US FAERS
81PancreatitisFAERS: 6US FAERS
82Violence-related symptomFAERS: 6US FAERS
83Visual ImpairmentFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
84AgeusiaFAERS: 5US FAERS
85AnorgasmiaFAERS: 5US FAERS
86Cerebrovascular accidentFAERS: 5US FAERS
87DehydrationFAERS: 5US FAERS
88Drug ineffective for unapproved indicationFAERS: 5US FAERS
89FlushingFAERS: 5US FAERS
90Inappropriate schedule of drug administrationFAERS: 5US FAERS
91Intentional self-injuryFAERS: 5US FAERS
92LymphadenopathyFAERS: 5US FAERS
93Mental impairmentFAERS: 5US FAERS
94Mental status changesFAERS: 5US FAERS
95Myocardial InfarctionFAERS: 5US FAERS
96OverdoseFAERS: 5US FAERS
97Personality ChangeFAERS: 5US FAERS
98Product use issueFAERS: 5US FAERS
99nervous system disorderFAERS: 5US FAERS
100Hallucinations, mixedFAERS: 4US FAERS
101HypotensionFAERS: 4US FAERS
102Initial insomniaFAERS: 4US FAERS
103Intentional dose omissionFAERS: 4US FAERS
104Prescribed overdoseFAERS: 4US FAERS
105Accidental exposure to product by childFAERS: 3US FAERS
106AcneFAERS: 3US FAERS
107Activities of daily living impairedFAERS: 3US FAERS
108Anaphylactic shockFAERS: 3US FAERS
109AngioedemaFAERS: 3US FAERS
110Blood cholesterol increasedFAERS: 3US FAERS
111Blood triglycerides increasedFAERS: 3US FAERS
112Cerebral disorderFAERS: 3US FAERS
113ChillsFAERS: 3US FAERS
114Cold sweatFAERS: 3US FAERS
115Drug administration errorFAERS: 3US FAERS
116Drug screen positiveFAERS: 3US FAERS
117DysarthriaFAERS: 3US FAERS
118DystoniaFAERS: 3US FAERS
119Emotional distressFAERS: 3US FAERS
120EpistaxisFAERS: 3US FAERS
121Euphoric moodFAERS: 3US FAERS
122Eye painFAERS: 3US FAERS
123Head discomfortFAERS: 3US FAERS
124Impaired work abilityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Joint stiffnessFAERS: 3US FAERS
126Lip swellingFAERS: 3US FAERS
127No adverse eventFAERS: 3US FAERS
128Obsessive thoughtsFAERS: 3US FAERS
129Ocular discomfortFAERS: 3US FAERS
130PhotophobiaFAERS: 3US FAERS
131PriapismFAERS: 3US FAERS
132ShockFAERS: 3US FAERS
133Toxicity to various agentsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
134Urinary RetentionFAERS: 3US FAERS
135Urinary hesitationFAERS: 3US FAERS
136Altered state of consciousnessFAERS: 2US FAERS
137AnosmiaFAERS: 2US FAERS
138ApathyFAERS: 2US FAERS
139AphasiaFAERS: 2US FAERS
140AsthenopiaFAERS: 2US FAERS
141Back PainFAERS: 2US FAERS
142Bladder discomfortFAERS: 2US FAERS
143Blood creatinine increasedFAERS: 2US FAERS
144Blood glucose decreasedFAERS: 2US FAERS
145Bronchial HyperreactivityFAERS: 2US FAERS
146BronchitisFAERS: 2US FAERS
147Burning sensationFAERS: 2US FAERS
148ClumsinessFAERS: 2US FAERS
149DeafnessFAERS: 2US FAERS
150DeliriumFAERS: 2US FAERS
151DependenceFAERS: 2US FAERS
152Depressed Level of ConsciousnessFAERS: 2US FAERS
153Diabetes mellitus inadequate controlFAERS: 2US FAERS
154Diabetic KetoacidosisFAERS: 2US FAERS
155Disease recurrenceFAERS: 2US FAERS
156DissociationFAERS: 2US FAERS
157Drug prescribing errorFAERS: 2US FAERS
158Drug screen false positiveFAERS: 2US FAERS
159Drug titration errorFAERS: 2US FAERS
160DysphoniaFAERS: 2US FAERS
161DysuriaFAERS: 2US FAERS
162Economic problemFAERS: 2US FAERS
163EructationFAERS: 2US FAERS
164ErythemaFAERS: 2US FAERS
165Extremity contractureFAERS: 2US FAERS
166Food cravingFAERS: 2US FAERS
167FormicationFAERS: 2US FAERS
168Gastrointestinal sounds abnormalFAERS: 2US FAERS
169HomicideFAERS: 2US FAERS
170HypersomniaFAERS: 2US FAERS
171Impaired driving abilityFAERS: 2US FAERS
172IncontinenceFAERS: 2US FAERS
173Maternal exposure during breast feedingFAERS: 2US FAERS
174MenorrhagiaFAERS: 2US FAERS
175Multiple drug overdoseFAERS: 2US FAERS
176Musculoskeletal PainFAERS: 2US FAERS
177MydriasisFAERS: 2US FAERS
178Obsessive-Compulsive DisorderFAERS: 2US FAERS
179Obsessive-compulsive symptomFAERS: 2US FAERS
180Oropharyngeal painFAERS: 2US FAERS
181Peripheral swellingFAERS: 2US FAERS
182PetechiaeFAERS: 2US FAERS
183Poor quality sleepFAERS: 2US FAERS
184Product formulation issueFAERS: 2US FAERS
185Product substitution issueFAERS: 2US FAERS
186PsoriasisFAERS: 2US FAERS
187RetchingFAERS: 2US FAERS
188SneezingFAERS: 2US FAERS
189SomnambulismFAERS: 2US FAERS
190StrabismusFAERS: 2US FAERS
191Therapy cessationFAERS: 2US FAERS
192VIIth nerve paralysisFAERS: 2US FAERS
193Vulvovaginal mycotic infectionFAERS: 2US FAERS
194jaundiceFAERS: 2US FAERS
195AbasiaFAERS: 1US FAERS
196Abnormal weight gainFAERS: 1US FAERS
197Accidental exposureFAERS: 1US FAERS
198AkathisiaFAERS: 1US FAERS
199Alanine Aminotransferase IncreasedFAERS: 1US FAERS
200Amphetamines positiveFAERS: 1US FAERS
201Anal sphincter atonyFAERS: 1US FAERS
202Angle Closure GlaucomaFAERS: 1US FAERS
203Apparent life threatening eventFAERS: 1US FAERS
204ArthritisFAERS: 1US FAERS
205Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
206AsphyxiaFAERS: 1US FAERS
207AsthmaFAERS: 1US FAERS
208AuraFAERS: 1US FAERS
209AutoscopyFAERS: 1US FAERS
210Bipolar DisorderFAERS: 1US FAERS
211BlepharospasmFAERS: 1US FAERS
212BlindnessFAERS: 1US FAERS
213Blood PressureFAERS: 1US FAERS
214Blood alkaline phosphatase abnormalFAERS: 1US FAERS
215Blood bilirubin abnormalFAERS: 1US FAERS
216Blood calcium abnormalFAERS: 1US FAERS
217Blood creatine phosphokinase increasedFAERS: 1US FAERS
218Blood glucose fluctuationFAERS: 1US FAERS
219Blood potassium decreasedFAERS: 1US FAERS
220Blood pressure fluctuationFAERS: 1US FAERS
221Blood sodium decreasedFAERS: 1US FAERS
222Bone painFAERS: 1US FAERS
223Breast tendernessFAERS: 1US FAERS
224BronchospasmFAERS: 1US FAERS
225Cardiac discomfortFAERS: 1US FAERS
226Change in sustained attentionFAERS: 1US FAERS
227Choking sensationFAERS: 1US FAERS
228ChromatopsiaFAERS: 1US FAERS
229Chronic diseaseFAERS: 1US FAERS
230ColitisFAERS: 1US FAERS
231Compulsive cheek bitingFAERS: 1US FAERS
232ConfabulationFAERS: 1US FAERS
233Contact lens intoleranceFAERS: 1US FAERS
234CystitisFAERS: 1US FAERS
235CystFAERS: 1US FAERS
236DementiaFAERS: 1US FAERS
237Dental discomfortFAERS: 1US FAERS
238DiscomfortFAERS: 1US FAERS
239Discontinued product administeredFAERS: 1US FAERS
240Dissociative AmnesiaFAERS: 1US FAERS
241Dissociative disorderFAERS: 1US FAERS
242Dreamy stateFAERS: 1US FAERS
243Drug DependenceFAERS: 1US FAERS
244Drug abuserFAERS: 1US FAERS
245Drug dispensing errorFAERS: 1US FAERS
246Drug dose titration not performedFAERS: 1US FAERS
247Drug effect incompleteFAERS: 1US FAERS
248DuodenitisFAERS: 1US FAERS
249DysgraphiaFAERS: 1US FAERS
250DysphemiaFAERS: 1US FAERS
251Ear discomfortFAERS: 1US FAERS
252EczemaFAERS: 1US FAERS
253Electrocardiogram abnormalFAERS: 1US FAERS
254EnuresisFAERS: 1US FAERS
255EpiscleritisFAERS: 1US FAERS
256Excessive sexual fantasiesFAERS: 1US FAERS
257Eye InfectionFAERS: 1US FAERS
258Eye irritationFAERS: 1US FAERS
259Failure of child resistant mechanism for pharmaceutical productFAERS: 1US FAERS
260Feeling ColdFAERS: 1US FAERS
261FrustrationFAERS: 1US FAERS
262Gastric BypassFAERS: 1US FAERS
263GastritisFAERS: 1US FAERS
264GastroenteritisFAERS: 1US FAERS
265Head BangingFAERS: 1US FAERS
266HungerFAERS: 1US FAERS
267HyperacusisFAERS: 1US FAERS
268HyperreflexiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
269Hypertensive crisisFAERS: 1US FAERS
270HyperventilationFAERS: 1US FAERS
271HypervigilanceFAERS: 1US FAERS
272HypokinesiaFAERS: 1US FAERS
273HypophagiaFAERS: 1US FAERS
274Impaired quality of lifeFAERS: 1US FAERS
275ImpatienceFAERS: 1US FAERS
276Inappropriate schedule of product administrationFAERS: 1US FAERS
277IncoherentFAERS: 1US FAERS
278Incorrect product administration durationFAERS: 1US FAERS
279Incorrect route of product administrationFAERS: 1US FAERS
280InfectionFAERS: 1US FAERS
281InfertilityFAERS: 1US FAERS
282Inflammatory painFAERS: 1US FAERS
283InfluenzaFAERS: 1US FAERS
284Intentional drug misuseFAERS: 1US FAERS
285Intentional product use issueFAERS: 1US FAERS
286Intercepted product prescribing errorFAERS: 1US FAERS
287Irritable Bowel SyndromeFAERS: 1US FAERS
288Joint injuryFAERS: 1US FAERS
289LacerationFAERS: 1US FAERS
290Lactose IntoleranceFAERS: 1US FAERS
291Loss of dreamingFAERS: 1US FAERS
292MastitisFAERS: 1US FAERS
293Mechanical urticariaFAERS: 1US FAERS
294MerycismFAERS: 1US FAERS
295Morbid thoughtsFAERS: 1US FAERS
296Muscle RigidityFAERS: 1US FAERS
297Musculoskeletal discomfortFAERS: 1US FAERS
298MyoclonusFAERS: 1US FAERS
299Nasal pruritusFAERS: 1US FAERS
300NasopharyngitisFAERS: 1US FAERS
301Neck PainFAERS: 1US FAERS
302Negative thoughtsFAERS: 1US FAERS
303NeuralgiaFAERS: 1US FAERS
304Neuroleptic Malignant SyndromeFAERS: 1US FAERS
305NocturiaFAERS: 1US FAERS
306Ocular icterusFAERS: 1US FAERS
307OnychoclasisFAERS: 1US FAERS
308Oral candidiasisFAERS: 1US FAERS
309Ovarian enlargementFAERS: 1US FAERS
310PallorFAERS: 1US FAERS
311Pancreatic PseudocystFAERS: 1US FAERS
312Panic DisorderFAERS: 1US FAERS
313ParasomniaFAERS: 1US FAERS
314Parkinsonian rest tremorFAERS: 1US FAERS
315Penile size reducedFAERS: 1US FAERS
316Physical assaultFAERS: 1US FAERS
317PolyarthritisFAERS: 1US FAERS
318Pre-existing condition improvedFAERS: 1US FAERS
319Premature EjaculationFAERS: 1US FAERS
320PresyncopeFAERS: 1US FAERS
321Procedural complicationFAERS: 1US FAERS
322Product dispensing errorFAERS: 1US FAERS
323Product lot number issueFAERS: 1US FAERS
324Product physical issueFAERS: 1US FAERS
325Product quality issueFAERS: 1US FAERS
326Product use in unapproved indicationFAERS: 1US FAERS
327Pulmonary HypertensionFAERS: 1US FAERS
328Rash erythematousFAERS: 1US FAERS
329Respiratory tract congestionFAERS: 1US FAERS
330RhabdomyolysisFAERS: 1US FAERS
331ScabFAERS: 1US FAERS
332Seizure like phenomenaFAERS: 1US FAERS
333Sinus bradycardiaFAERS: 1US FAERS
334SinusitisFAERS: 1US FAERS
335Skin UlcerFAERS: 1US FAERS
336Skin texture abnormalFAERS: 1US FAERS
337Sleep TalkingFAERS: 1US FAERS
338Slow speechFAERS: 1US FAERS
339SluggishnessFAERS: 1US FAERS
340Splenic vein thrombosisFAERS: 1US FAERS
341SplenomegalyFAERS: 1US FAERS
342Spontaneous penile erectionFAERS: 1US FAERS
343Status EpilepticusFAERS: 1US FAERS
344StomatitisFAERS: 1US FAERS
345Supraventricular tachycardiaFAERS: 1US FAERS
346Tardive DyskinesiaFAERS: 1US FAERS
347Temperature intoleranceFAERS: 1US FAERS
348Tension HeadacheFAERS: 1US FAERS
349TheftFAERS: 1US FAERS
350Therapeutic product effect decreasedFAERS: 1US FAERS
351Therapeutic product effective for unapproved indicationFAERS: 1US FAERS
352ThrombosisFAERS: 1US FAERS
353ToothacheFAERS: 1US FAERS
354Toxicologic test abnormalFAERS: 1US FAERS
355UlcerFAERS: 1US FAERS
356UnemploymentFAERS: 1US FAERS
357Urinary IncontinenceFAERS: 1US FAERS
358Vasodilation procedureFAERS: 1US FAERS
359Vitreous DetachmentFAERS: 1US FAERS
360Vulvovaginal burning sensationFAERS: 1US FAERS
361Vulvovaginal drynessFAERS: 1US FAERS
362Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
363pH urine increasedFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.